Webinar description

Treating substance use disorders is one of the most pressing issues in Canada. Every year, substance use disorders kill thousands of Canadians and cost the healthcare and criminal justice systems billions of dollars. While conventional treatment methods remain the frontline option, psychedelic-assisted therapy has shown significant potential in treating challenging cases of substance use disorder. This webinar will bring together an expert in drug-related harm, a psychiatric historian, a clinical researcher, a physician, and a firefighter with lived experience to provide a comprehensive discussion on the role of psychedelic-assisted therapy in the treatment of substance use disorders.

    1. The Role of Psychedelic-Assisted Therapy in the Treatment of Substance Use Disorders

About this webinar

  • $10.00
  • 1 hour of video content

Panelists

  • Erika Dyck, Professor and Canada Research Chair, University of Saskatchewan

  • Timothy Stockwell, Director of Canadian Institute for Substance Use Research

  • Bernard Le Foll, Senior Scientist at CAMH, Chair of Addiction Psychiatry University of Toronto

  • Pamela Kryskow, Medical doctor Medical Lead of Roots To Thrive

  • Darren Wayne, Firefighter and Paramedic

Learning Objectives

  • Learn about the negative impact of substance use disorders, with a particular spotlight on alcohol and opioids, and their related social costs and harms in Canada.

  • Learn about policies and interventions that can increase or decrease substance use related harms as well as the best known traditional treatment methods.

  • Gain an understanding of the history of psychedelic-assisted therapy as a treatment method for alcohol use disorder in Canada.

  • Discover current clinical trials in Canada that are gathering scientific evidence on the efficacy of psychedelic-assisted therapy on substance use disorders.

  • Gain an in-depth understanding on the research design of an upcoming clinical trial at Toronto’s CAMH on the impact of psilocybin on patients with major depressive disorder and alcohol use disorder.

  • Explore the neurological, psychological and spiritual mechanisms by which psychedelic-assisted therapy treats substance use disorder.

  • Understand current legal pathways and existing barriers for access to psychedelic-assisted therapy for substance use disorders.

  • Find out from someone with lived experience treating their substance use disorder with psychedelic-assisted therapy how it improved their life.

Start your learning journey